Monness, Crespi, Hardt Initiates Coverage On Marqeta with Buy Rating, Announces Price Target of $7.5
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.